Article
Pyrogallol-Phloroglucinol-6,6-Bieckolon Attenuates Vascular Smooth Muscle Cell Proliferation and Phenotype Switching in Hyperlipidemia through Modulation of Chemokine Receptor 5.
Marine drugs - 27 Jul 2020
Oh Seyeon, Son Myeongjoo, Park Chul-Hyun, Jang Ji Tae, Son Kuk Hui, Byun Kyunghee
Abstract excerpt
Hyperlipidemia induces vascular smooth muscle cell (VSMC) proliferation and phenotype switching from contractile to synthetic. This process is involved in arterial remodeling via the chemokine ligand 5 (CCL5)/chemokine receptor 5 (CCR5) pathway. Arterial remodeling is related to atherosclerosis or intimal hyperplasia. The purpose of this study was to evaluate whether pyrogallol-phloroglucinol-6,6-bieckol (PPB)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.